Gentamicin Dosing in the Newborn
- 1 July 1984
- journal article
- research article
- Published by S. Karger AG in Developmental Pharmacology and Therapeutics
- Vol. 7 (4) , 263-272
- https://doi.org/10.1159/000457173
Abstract
Gentamicin 2.5 mg/kg was given to 60 term and preterm neonates. Serum gentamicin concentrations were determined at 1,7 and 11 h postinfusion. Linear regression analysis was used to determine half-life and volume of distribution. From these data a new dosing regimen and a predicted steady-state peak and trough gentamicin concentration were determined for each neonate. The predicted peak and trough were compared to a measured peak or trough drawn at least 48 h later. Criteria for successful peaks were met in 93% of the patients, while criteria for successful troughs were met in 83%. Individualized gentamicin dosing in the newborn based on a one-compartment open pharmacokinetic model is a useful clinical tool in predicting peak and trough gentamicin concentrations.Keywords
This publication has 2 references indexed in Scilit:
- Gentamicin pharmacokinetics in 1,640 patients: method for control of serum concentrationsAntimicrobial Agents and Chemotherapy, 1982
- Kinetic model for gentamicin dosing with the use of individual patient parametersClinical Pharmacology & Therapeutics, 1977